Ignite Creation Date:
2024-05-06 @ 1:20 AM
Last Modification Date:
2024-10-26 @ 11:02 AM
Study NCT ID:
NCT01781702
Status:
COMPLETED
Last Update Posted:
2013-08-09
First Post:
2013-01-30
Brief Title:
Phase 3 Study of Pelubiprofen Tab Celebrex Cap in Rheumatoid Arthritis Patients
Sponsor:
Daewon Pharmaceutical Co Ltd
Organization:
Daewon Pharmaceutical Co Ltd
Study Overview
Official Title:
A Randomized Double-blind Multicenter Phase 3 Study of Pelubiprofen Tab Celebrex Cap for Comparative Evaluation of Safety Efficacy in Rheumatoid Arthritis Patients
Status:
COMPLETED
Status Verified Date:
2013-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A Randomized Double-blind Multicenter Phase 3 Study of Pelubiprofen Tab Celebrex Cap for Comparative Evaluation of Safety Efficacy in Rheumatoid Arthritis Patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None